NeuroRx plans pivotal trial after seeing hints of efficacy in suicidal patients

NeuroRx plans pivotal trial after seeing hints of efficacy in suicidal patients

Source: 
Fierce Biotech
snippet: 

NeuroRx is planning to move NRX-101 into phase 2b/3 after detecting signs of efficacy in a feasibility trial in patients with suicidal bipolar depression. The small phase 2 feasibility study linked fixed-dose combination NRX-101 to improved scores on a depression rating scale.